• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

New York ODs seek expanded scope of practice

Article

New York is one of the two states that have yet to allow optometrists to prescribe certain oral medications, but the state’s ODs are looking to change that.

Albany, NY-New York is one of the two states that have yet to allow optometrists to prescribe certain oral medications, but the state’s ODs are looking to change that

The New York State Optometric Association recently went to lobby in favor of the bill, which has not made it out of committee

“Optometrists in New York are seeking authority to administer and prescribe medication orally that we currently prescribe topically. There is no difference in potential side effects, drug interactions, or mechanism of action from what we already prescribe every day,” NYSOA President Christopher Colburn, OD, told Optometry Times. “This legislation simply permits an additional route of administration for medication that patients in New York require to most effectively manage their eye conditions. Requiring patients in New York to visit multiple providers, in many cases utilizing emergency rooms, for conditions that are clearly within optometry’s domain, is cumbersome for the patient and wasteful of healthcare resources. It is inconceivable that residents of New York continue to be denied access to necessary care that they can receive in 48 other states.”

The bill would require ODs to complete 25 hours of phase-3 therapeutic pharmaceutical agent certification course of didactic education. ODs in New York say the bill could fill a need for rural patients who may not be able to get to an ophthalmologist. Ophthalmologists, however, are not in favor of the bill.

Next: ASCO receives grant from Allergan Foundation to support career video

New laws restrict MVC plan contracts with ODs in Kansas and Vermont

Related Videos
World Optometry Day 2024
Nicholas Gilberg, OD, gives a tutorial on EssilorLuxottica's Leonardo team practice management programs
Chris and Jamie Shyer, Zyloware Eyewear co-CEOs, after their NOW Optical Lifetime Achievement award win at Vision Expo East
Jessica Steen, OD, FAAO, discusses systemic medication and ocular adverse effects at Vision Expo East 2024
At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.
Brujic at Rinsada Booth at Vision Expo East 2024
© 2024 MJH Life Sciences

All rights reserved.